All CME content presented at AACE Annual Meeting 2023 is now available on-demand! The sessions and lectures focus on the latest scientific and clinical discoveries in the field of endocrinology to help you achieve the best outcomes for the diagnosis, management, and treatment of patients living with endocrine diseases. Watch presenters’ slides while listening to fully synchronized audio as if you were actually attending each session.

AACE 2023 On-Demand Features:

• Over 50 sessions including the updated AACE Type 2 Diabetes Algorithm
• Over 100 speakers
• Up to 47.25 CME and MOC

ACCME

The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American College of Endocrinology (ACE) designates this enduring activity for a maximum of 47.25 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

Provider approved by the California Board of Registered Nursing, Provider Number 17762, for 47.25 contact hours.

ABOM

Applicants for certification through the American Board of Obesity Medicine (ABOM) may claim up to 8.25 Group Two CME credits toward the ABOM application requirement when providing a CME certificate or transcript showing you attended the obesity and nutrition track sessions.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 47.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit. 

By the end of the meeting, participants will be able to:

• Discuss the latest scientific and clinical discoveries in the field of endocrinology, diabetes, and metabolism. 
• Apply newfound knowledge to diagnosis and management for improved patient outcomes.  
• Assess the potential applications of emerging scientific advances that affect the practice of endocrinology.
• Empower participants to educate their patients regarding clinical treatment options.  

This activity is intended for medical professionals from the field of clinical endocrinology at all stages in their career including clinical endocrinologists, primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists, registered dietitians, medical students, residents and fellows in training. 

Disclosure and Conflicts of Interest Policy

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Planner Disclosures

View/Download

Faculty Disclosures

View/Download

This activity is supported by educational grants from the following:

• Abbott Diabetes Care
• Lilly USA, LLC
• Pfizer-Merck Alliance
• Radius Health
• Rhythm Pharmaceuticals